Dual-Light Photodynamic Therapy Effectively Eliminates Streptococcus Oralis Biofilms.


Journal

Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques
ISSN: 1482-1826
Titre abrégé: J Pharm Pharm Sci
Pays: Switzerland
ID NLM: 9807281

Informations de publication

Date de publication:
2021
Historique:
entrez: 24 9 2021
pubmed: 25 9 2021
medline: 29 1 2022
Statut: ppublish

Résumé

During cancer treatment, oral mucositis due to radiotherapy or chemotherapy often leads to disruption of the oral mucosa, enabling microbes to invade bloodstream. Viridans streptococcal species are part of the healthy oral microbiota but can be frequently isolated from the blood of neutropenic patients.  We have previously shown the antibacterial efficacy of dual-light, the combination of antibacterial blue light (aBL) and indocyanine green photodynamic therapy (aPDT). Here, we investigated the dual-light antibacterial action against four-day Streptococcus oralis biofilm. In addition, while keeping the total radiant exposure constant at 100J/cm2, we investigated the effect of changing the different relative light energies of aBL and aPDT to the antibacterial potential. The dual-light had a significant antibacterial effect in all the tested combinations. Dual-light can be used as an effective disinfectant against S. oralis biofilm.

Identifiants

pubmed: 34559627
doi: 10.18433/jpps32084
doi:

Substances chimiques

Anti-Bacterial Agents 0
Indocyanine Green IX6J1063HV

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

484-487

Auteurs

Jessica Hentilä (J)

Department of Oral and Maxillofacial Surgery, University of Helsinki and Helsinki University Hospital, Finland.

Noora Laakamaa (N)

Department of Oral and Maxillofacial Surgery, University of Helsinki and Helsinki University Hospital, Finland.

Timo Sorsa (T)

Department of Oral and Maxillofacial Surgery, University of Helsinki and Helsinki University Hospital, Finland and Department of Oral Medicine, Karolinska Institute, Huddinge, Sweden.

Jukka Meurman (J)

Department of Oral and Maxillofacial Surgery, University of Helsinki and Helsinki University Hospital, Finland.

Hanna Välimaa (H)

Department of Oral and Maxillofacial Surgery and Department of Virology, University of Helsinki and Helsinki Hospital, Finland.

Sakari Nikinmaa (S)

Department of Neuroscience and Biomedical Engineering, Aalto University, Finland.

Esko Kankuri (E)

Department of Neuroscience and Biomedical Engineering, Aalto University, Finland.

Tuomas Tauriainen (T)

Heart and Lung Center, Meilahti Hospital, Helsinki, Finland.

Tommi Pätilä (T)

Department of Congenital Heart Surgery and Organ Transplantation, New Children's Hospital, University of Helsinki, Finland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH